Halozyme Therapeutics
HALO
$33.85
Share price
-0.91%
Change (1 day)
-26.73%
Change (1 year)
Categories
Halozyme Therapeutics (HALO) - Total assets
Total assets on the balance sheet as of December 2022 : $1.84 B
According to Halozyme Therapeutics's latest financial reports the company's total assets are $1.84 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Halozyme Therapeutics - Total assets on balance sheet (from 2002 to 2022)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $1.84 B | 66.74% |
| 2021-12-31 | $1.10 B | 90.44% |
| 2020-12-31 | $0.57 B | 2.48% |
| 2019-12-31 | $0.56 B | 28.54% |
| 2018-12-31 | $0.44 B | -15.33% |
| 2017-12-31 | $0.51 B | 98.82% |
| 2016-12-31 | $0.26 B | 43.86% |
| 2015-12-31 | $0.18 B | 9.53% |
| 2014-12-31 | $0.16 B | 63.05% |
| 2013-12-31 | $0.10 B | -24.45% |
| 2012-12-31 | $0.13 B | 104.88% |
| 2011-12-31 | $65.75 M | -28.01% |
| 2010-12-31 | $91.34 M | 18.4% |
| 2009-12-31 | $77.14 M | 0.77% |
| 2008-12-31 | $76.56 M | -26% |
| 2007-12-31 | $0.10 B | 124.47% |
| 2006-12-31 | $46.09 M | 124.72% |
| 2005-12-31 | $20.51 M | 25.03% |
| 2004-12-31 | $16.4 M | 34421.69% |
| 2003-12-31 | $0.04 M | -51.14% |
| 2002-12-31 | $0.09 M | 272.22% |
| 2001-12-31 | $0.02 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $187.37 B | 10,075.24% | 🇺🇸 USA |
 Pfizer PFE | $197.20 B | 10,608.87% | 🇺🇸 USA |
 Eli Lilly LLY | $53.16 B | 2,786.92% | 🇺🇸 USA |
 Sanofi SNY | $135.71 B | 7,269.82% | 🇫🇷 France |
 Baxter BAX | $28.29 B | 1,436.29% | 🇺🇸 USA |
 MannKind Corp MNKD | $0.29 B | -83.97% | 🇺🇸 USA |